Author's Accepted Version
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Clinical Guide to Epileptic Syndromes and Their Treatment
Published August 13, 2008 as 10.3174/ajnr.A1231 dures and principles of treatment. These chapters are particu- BOOK REVIEW larly important for readers unfamiliar with the overall clinical presentation of the epilepsies and their diagnostic evaluation. A Clinical Guide to Epileptic Omitting these topics was a certain pitfall that has been Syndromes and Their Treatment, avoided. Basic techniques used in the evaluation of patients with of epilepsy, including anatomic and functional neuroim- 2nd ed. aging, are also included. The discussion of the relative value of C.P. Panayiotopoulos, ed. London, UK: Springer-Verlag; 2007, 578 EEG and its problems is particularly valuable. pages, 100 illustrations, $99.00. Subsequent chapters are devoted to the meat of the book, the epilepsy syndromes. These are presented in age-based he syndromic classification of epileptic seizures has been chronologic order, beginning with syndromes in the neonate evolving for more than a quarter century. Piggy-backed T and infant and continuing through syndromes in adults. onto major advances in neurophysiology and neuroimaging, Complete coverage of reflex seizures and reflex epilepsies in the current nomenclature of specific clinical epilepsy syn- chapter 16 is particularly welcome. Chapter 17 covers a group dromes now supersedes earlier seizure classifications based of disorders that are associated with epileptic seizures. The exclusively on seizure types. The practice of epilepsy has thus chapter gives excellent coverage of these disorders but makes joined mainstream medicine through its newfound ability to no pretenses at being comprehensive. For example, coverage link the signs and symptoms of epilepsy with specific under- of important disorders with epilepsy such as the Wolf- lying disorders. -
Prognostic Utility of Hypsarrhythmia Scoring in Children with West
Clinical Neurology and Neurosurgery 184 (2019) 105402 Contents lists available at ScienceDirect Clinical Neurology and Neurosurgery journal homepage: www.elsevier.com/locate/clineuro Prognostic utility of hypsarrhythmia scoring in children with West syndrome T after ketogenic diet ⁎ Yunjian Zhang1, Lifei Yu1, Yuanfeng Zhou, Linmei Zhang, Yi Wang, Shuizhen Zhou Department of Pediatric Neurology, Children’s Hospital of Fudan University, China ARTICLE INFO ABSTRACT Keywords: Objective: The aim of this study was to evaluate the clinical efficacy and electroencephalographic (EEG) changes West syndrome of West syndrome after ketogenic diet (KD) therapy and to explore the correlation of EEG features and clinical Ketogenic diet efficacy. EEG Patients and methods: We retrospectively studied 39 patients with West syndrome who accepted KD therapy from Hypsarrhythmia May 2011 to October 2017. Outcomes including clinical efficacy and EEG features with hypsarrhythmia severity scores were analyzed. Results: After 3 months of treatment, 20 patients (51.3%) had ≥50% seizure reduction, including 4 patients (10.3%) who became seizure-free. After 6 months of treatment, 4 patients remained seizure free, 12 (30.8%) had 90–99% seizure reduction, 8 (20.5%) had a reduction of 50–89%, and 15 (38.5%) had < 50% reduction. Hypsarrhythmia scores were significantly decreased at 3 months of KD. They were associated with seizure outcomes at 6 months independent of gender, the course of disease and etiologies. Patients with a hypsar- rhythmia score ≥8 at 3 months of therapy may not be benefited from KD. Conclusion: Our findings suggest a potential benefit of KD for patients with drug-resistant West syndrome. Early change of EEG after KD may be a predictor of a patient’s response to the therapy. -
Epilepsy & My Child Toolkit
Epilepsy & My Child Toolkit A Resource for Parents with a Newly Diagnosed Child 136EMC Epilepsy & My Child Toolkit A Resource for Parents with a Newly Diagnosed Child “Obstacles are the things we see when we take our eyes off our goals.” -Zig Ziglar EPILEPSY & MY CHILD TOOLKIT • TABLE OF CONTENTS Introduction Purpose .............................................................................................................................................5 How to Use This Toolkit ....................................................................................................................5 About Epilepsy What is Epilepsy? ..............................................................................................................................7 What is a Seizure? .............................................................................................................................8 Myths & Facts ...................................................................................................................................8 How is Epilepsy Diagnosed? ............................................................................................................9 How is Epilepsy Treated? ..................................................................................................................10 Managing Epilepsy How Can You Help Manage Your Child’s Care? ...............................................................................13 What Should You Do if Your Child has a Seizure? ............................................................................14 -
Initiating an Epilepsy Surgery Program with Limited Resources in Indonesia
www.nature.com/scientificreports OPEN Initiating an epilepsy surgery program with limited resources in Indonesia Muhamad Thohar Arifn1*, Ryosuke Hanaya2, Yuriz Bakhtiar1, Aris Catur Bintoro3, Koji Iida4, Kaoru Kurisu4, Kazunori Arita2, Jacob Bunyamin1, Rofat Askoro1, Surya Pratama Brilliantika1, Novita Ikbar Khairunnisa1 & Zainal Muttaqin1 To share the experiences of organizing the epilepsy surgery program in Indonesia. This study was divided into two periods based on the presurgical evaluation method: the frst period (1999–2004), when interictal electroencephalogram (EEG) and magnetic resonance imaging (MRI) were used mainly for confrmation, and the second period (2005–2017), when long-term non-invasive and invasive video-EEG was involved in the evaluation. Long-term outcomes were recorded up to December 2019 based on the Engel scale. All 65 surgical recruits in the frst period possessed temporal lobe epilepsy (TLE), while 524 patients were treated in the second period. In the frst period, 76.8%, 16.1%, and 7.1% of patients with TLE achieved Classes I, II, and III, respectively, and in the second period, 89.4%, 5.5%, and 4.9% achieved Classes I, II, and III, respectively, alongside Class IV, at 0.3%. The overall median survival times for patients with focal impaired awareness seizures (FIAS), focal to bilateral tonic–clonic seizures and generalized tonic–clonic seizures were 9, 11 and 11 years (95% CI: 8.170– 9.830, 10.170–11.830, and 7.265–14.735), respectively, with p = 0.04. The utilization of stringent and selective criteria to reserve surgeries is important for a successful epilepsy program with limited resources. -
Epileptic Spasms in Clusters with Focal EEG Paroxysms
CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Seizure 35 (2016) 88–92 Contents lists available at ScienceDirect Seizure jou rnal homepage: www.elsevier.com/locate/yseiz Epileptic spasms in clusters with focal EEG paroxysms: A study of 12 patients a, a b a Roberto H. Caraballo *, Gabriela Reyes , Raffaele Falsaperla , Belen Ramos , c a a a Aliria Carpio Ruiz , Cecilia Aguilar Fernandez , Gabriela Peretti , Lucas Beltran a Department of Neurology, Hospital de Pediatrı´a ‘‘Prof. Dr. Juan P. Garrahan’’, Buenos Aires, Argentina b UOC NeuropsichiatriaInfantile, Policlinico Universitario, Universita` di Catania, Italia c Department of Neurology, Hospital de Nin˜os J. M. de los Rı´os, Caracas, Venezuela A R T I C L E I N F O A B S T R A C T Article history: Objective: We analyzed the electroclinical features, etiology, treatment, and outcome of 12 patients with Received 22 September 2015 West syndrome (WS) associated with focal hypsarrhythmia (FH). Received in revised form 8 January 2016 Methods: Between February 2005 and July 2013, 12 patients met the electroclinical diagnostic criteria of Accepted 9 January 2016 WS associated with FH. Hypsarrhythmia was considered to be focal when two or three brain lobes were involved. Patients with hemihypsarrhythmia were excluded. Keywords: Results: All patients had epileptic spasms (ES) in clusters of a structural etiology. Four had a Clusters porencephalic cyst, two had focal cortical dysplasia, two had open-lip schizencephaly, and one each had Encephalopathy unilateral polymicrogyria, shunted hydrocephalus, glioma, and cerebral hemiatrophy. Age at ES onset Epileptic spasms was between 2 and 8 months, with a mean age of 5 and a median age of 6 months. -
September | 2013 ISSN 1660-3656 Epileptologie | 30. Jahrgang
Epileptologie | 30. Jahrgang September | 2013 ISSN 1660-3656 Epilepsie-Liga Seefeldstrasse 84 Postfach 1084 CH-8034 Zürich Redaktionskommission Thomas Dorn | Zürich Reinhard E. Ganz | Zürich Martinus Hauf | Tschugg Hennric Jokeit | Zürich Christian M. Korff | Genève Günter Krämer | Zürich (Vorsitz) Inhalt Oliver Maier | St. Gallen Andrea O. Rossetti | Lausanne Stephan Rüegg | Basel Kaspar Schindler | Bern Editorial 147 – 149 Serge Vulliémoz | Genève Combination of Electroencephalographic and Magnetic Resonance Imaging to Beirat Characterize Epileptic Networks Christoph M. Michel 150 – 157 Alexandre Datta | Basel Thomas Grunwald | Zürich Structure, Function and Genes: Christian W. Hess | Bern What Can We Learn from MRI Anna Marie Hew-Winzeler | Zürich Giorgi Kuchukhidze, Eugen Trinka 158 – 166 Günter Krämer | Zürich Theodor Landis | Genève Hereditäre epileptische Enzephalopathie Malin Maeder | Lavigny mit Amelogenesis imperfecta Klaus Meyer | Tschugg Kohlschütter-Tönz-Syndrom Christoph Michel | Genève (KTZS). Bericht über einen weiteren, Christoph Pachlatko | Zürich posthum erfassten Patienten aus der Monika Raimondi | Lugano Zentralschweiz. Andrea O. Rossetti | Lausanne Otmar Tönz, Bernhard Steiner, Anna Stephan Rüegg | Basel Schossig, Johannes Zschocke, Markus Schmutz | Basel Alfried Kohlschütter 167– 174 Margitta Seeck | Genève Urs Sennhauser | Hettlingen Epilepsie-Liga-Mitteilungen 175 – 198 Franco Vassella | Bremgarten Kongresskalender 199 – 200 Schweizerische Liga gegen Epilepsie Ligue Suisse contre l’Epilepsie Lega Svizzera contro l’Epilessia Swiss League Against Epilepsy Richtlinien für die Autoren Allgemeines - Zusammenfassung, Résumé und englischer Ab- stract (mit Titel der Arbeit): Ohne Literaturzitate Epileptologie veröffentlicht sowohl angeforderte als und Akronyme sowie unübliche Abkürzungen (je auch unaufgefordert eingereichte Manuskripte über maximal 250 Wörter). alle Themen der Epileptologie. Es werden in der Regel - Text: Dabei bei Originalarbeiten Gliederung in Ein- nur bislang unveröffentlichte Arbeiten angenommen. -
Age of Onset in Idiopathic (Genetic) Generalized Epilepsies: Clinical and EEG
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Seizure 21 (2012) 417–421 Contents lists available at SciVerse ScienceDirect Seizure jou rnal homepage: www.elsevier.com/locate/yseiz Age of onset in idiopathic (genetic) generalized epilepsies: Clinical and EEG findings in various age groups a,b, a b Ali A. Asadi-Pooya *, Mehrdad Emami , Michael R. Sperling a Neurosciences Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran b Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, USA A R T I C L E I N F O A B S T R A C T Article history: Purpose: The prevalence and differences of idiopathic (genetic) generalized epilepsies (IGEs) with Received 5 February 2012 atypical age of onset compared to classical IGEs is a matter of debate. We tried to determine the clinical Received in revised form 11 April 2012 and EEG characteristics of IGEs in various age groups. Accepted 11 April 2012 Methods: All patients with a clinical diagnosis of IGE were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences from 2008 through 2011. We subdivided the patients into four Keywords: different age groups: 4 years of age and under, 5–11 years, 12–17 years, and finally, 18 years and above, Idiopathic generalized epilepsy at the time of their epilepsy onset. Syndromic diagnosis, sex ratio, seizure types and EEG findings were Age of onset compared. Statistical analyses were performed using Pearson Chi square test. Seizure type EEG Results: 2190 patients with epilepsy were registered. -
Fostering Epilepsy Care in Europe All Rights Reserved
EPILEPSY IN THE WHO EUROPEAN REGION: Fostering Epilepsy Care in Europe All rights reserved. No part of this publication may be reproduced, stored in a database or retrieval system, or published, in any form or any way, electronically, mechanically, by print, photoprint, microfilm or any other means without prior written permission from the publisher. Address requests about publications of the ILAE/IBE/WHO Global Campaign Against Epilepsy: Global Campaign Secretariat SEIN P.O. Box 540 2130 AM Hoofddorp The Netherlands e-mail: [email protected] ISBN NR. 978-90-810076-3-4 Layout/ Printing: Paswerk Bedrijven, Cruquius, Netherlands Table of contents Foreword ................................................................................................................................................. 4 Preface ................................................................................................................................................. 5 Acknowledgements ........................................................................................................................................ 6 Tribute ................................................................................................................................................. 7 Abbreviations ................................................................................................................................................. 8 Background information on the European Region ......................................................................................... -
Infantile Spasms: an Update on Pre-Clinical Models and EEG Mechanisms
children Review Infantile Spasms: An Update on Pre-Clinical Models and EEG Mechanisms Remi Janicot, Li-Rong Shao and Carl E. Stafstrom * Division of Pediatric Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; [email protected] (R.J.); [email protected] (L.-R.S.) * Correspondence: [email protected]; Tel.: +1-(410)-955-4259; Fax: +1-(410)-614-2297 Received: 19 November 2019; Accepted: 23 December 2019; Published: 6 January 2020 Abstract: Infantile spasms (IS) is an epileptic encephalopathy with unique clinical and electrographic features, which affects children in the middle of the first year of life. The pathophysiology of IS remains incompletely understood, despite the heterogeneity of IS etiologies, more than 200 of which are known. In particular, the neurobiological basis of why multiple etiologies converge to a relatively similar clinical presentation has defied explanation. Treatment options for this form of epilepsy, which has been described as “catastrophic” because of the poor cognitive, developmental, and epileptic prognosis, are limited and not fully effective. Until the pathophysiology of IS is better clarified, novel treatments will not be forthcoming, and preclinical (animal) models are essential for advancing this knowledge. Here, we review preclinical IS models, update information regarding already existing models, describe some novel models, and discuss exciting new data that promises to advance understanding of the cellular mechanisms underlying the specific EEG changes seen in IS—interictal hypsarrhythmia and ictal electrodecrement. Keywords: infantile spasms; West syndrome; epilepsy; childhood; epileptic encephalopathy; electroencephalogram (EEG); hypsarrhythmia; electrodecrement; animal model 1. Introduction Epileptic encephalopathies (EEs) are a spectrum of disorders that mostly begin during infancy and have poor neurological and behavioral outcomes. -
Prognostic Utility of Clinical Epilepsy Severity Score Versus Pretreatment
EEGXXX10.1177/1550059416662425Clinical EEG and NeuroscienceSehgal et al 662425research-article2016 Neurology/Medicine Clinical EEG and Neuroscience 2017, Vol. 48(4) 280 –287 Prognostic Utility of Clinical Epilepsy Severity © EEG and Clinical Neuroscience Society (ECNS) 2016 Reprints and permissions: Score Versus Pretreatment Hypsarrhythmia sagepub.com/journalsPermissions.nav DOI: 10.1177/1550059416662425 Scoring in Children With West Syndrome journals.sagepub.com/home/eeg Rachna Sehgal, DM1,2, Sheffali Gulati, MD1, Savita Sapra, PhD1, Manjari Tripathi, MD3, Ravinder Mohan Pandey, MD4, and Madhulika Kabra, MD1 Abstract This cross-sectional study assessed the impact of clinical epilepsy severity and pretreatment hypsarrhythmia severity on epilepsy and cognitive outcomes in treated children with West syndrome. Thirty-three children, aged 1 to 5 years, with infantile spasms were enrolled if pretreatment EEG records were available, after completion of ≥1 year of onset of spasms. Neurodevelopment was assessed by Development Profile 3 and Gross Motor Function Classification System. Epilepsy severity in the past 1 year was determined by the Early Childhood Epilepsy Severity Score (E-Chess). Kramer Global Score of hypsarrhythmia severity was computed. Kramer Global Score (≤8) and E-Chess (≤9) in the past 1 year were associated with favorable epilepsy outcome but not neurodevelopmental or motor outcome. Keywords West syndrome, outcomes, neurodevelopment, epilepsy, motor, Kramer Global Score, E-Chess Received July 2, 2015; revised June 28, 2016; -
Drug Class Review Newer Anticonvulsant Agents 28:12:92 Anticonvulsants, Other
Drug Class Review Newer Anticonvulsant Agents 28:12:92 Anticonvulsants, Other Brivaracetam (Briviact®) Clobazam (Onfi®) Eslicarbazepine (Aptiom®) Ezogabine (Potiga®) Felbamate (Felbatol®, others) Gabapentin (Neurontin®) Lacosamide (Vimpat®, others) Lamotrigine (Lamictal®, others) Levetiracetam (Keppra®, others) Oxcarbazepine (Trileptal®, Oxtellar XR®, others) Perampanel (Fycompa®) Pregabalin (Lyrica ®) Rufinamide (Banzel®) Tiagabine (Gabitril®) Topiramate (Topamax ®, Trokendi XR, Qudenxi XR, others) Vigabatrin (Sabril®) Zonisamide (Zonergan ®, others) Final Report June 2016 Review prepared by: Vicki Frydrych, Clinical Pharmacist University of Utah College of Pharmacy Copyright © 2016 by University of Utah College of Pharmacy Salt Lake City, Utah. All rights reserved. Table of Contents Introduction ....................................................................................................................... 1 Table 1: Comparison of Newer Anticonvulsant Agents ...................................... 2 Table 2: FDA-Approved Indications for Newer Anticonvulsant Agents ........... 16 Disease Overview ............................................................................................................ 17 Table 3: The International League Against Epilepsy Classification of Seizures ............................................................................................... 19 Table 4: Newer Antiepileptic Drugs Which May Exacerbate Seizures ............. 21 Table 5: Clinical Practice Guideline Recommendations for Epilepsy ............. -
10/21/2020 1 Outcome of Pediatric Epilepsies in Adulthood
10/21/2020 Outcome of Pediatric Epilepsies in Adulthood No financial disclosure Suad Khalil, MD Pediatric Neurologist and Epileptologist MSU- Assistant Professor 1 2 What does the term Objectives “outcome” mean ?? • History of seizures (remission or persistence of seizures, evolution of seizure pattern throughout life and response to AEDs) • Discuss global aspects of outcome of pediatric • The natural course of the disease causing the seizures epilepsies during adulthood • The comorbidities (changes in cognition, psychiatric • Discuss specific aspects of outcome in some symptoms, and sometimes of the neurological condition), epileptic syndromes, and focus on epilepsies that • The risk of mortality begin during infancy, childhood and adolescence • The familial and social impact of a disease that has started in childhood 3 4 Epilepsy Syndromes Age Seizure semiology EEG data Comorbidities 5 6 1 10/21/2020 The Epilepsy Syndrome Solar System Seizure types Focal Generalized Unknown Idiopathic onset onset onset Etiology JAE Epilepsy with Primary reading JME epilepsy 10 yr grand-mal Structural seizures upon awakening Epilepsies with BECTS 1 yr specific modes Genetic Childhood of activation Childhood 1 mo absence epilepsy Generalized Epilepsy types epilepsy with BMEI occipital BNC Combined Infectious paroxysms BNFC Focal Generalized Unknown West Generalized EME EIEE Syndrome & Focal Cryptogenic or Symptomatic Focal Lennox-Gastault Epilepsies Neonatal Seizures Syndrome Metabolic Focal Epilepsy with myoclono-astatic Rasmussen’s Comorbidities seizures